Harmony Biosciences Holdings, Inc.
HRMYNasdaqCIK 1802665HealthcareFiscal year ends Dec 31
Reports and events: 115 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-3016:15 ET | 8-K/A | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-26-120673 |
| 2026-10-1308:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-115282 |
| 2026-08-0408:16 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001104659-26-090090 |
| 2026-08-0408:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-090086 |
| 2026-07-1608:35 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-084095 |
| 2026-05-1416:31 ET | 8-K | 5.07 Shareholder vote results | 0001104659-26-061237 |
| 2026-05-0709:24 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-056786 |
| 2026-05-0708:16 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001104659-26-056720 |
| 2026-04-1408:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-042886 |
| 2026-04-0308:00 ET | DEF 14A | Proxy statementPeriod 2026-05-14 | 0001104659-26-039449 |
| 2026-04-0208:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-038888 |
| 2026-02-2408:16 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001104659-26-018859 |
| 2026-02-2408:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-018858 |
| 2026-01-1208:20 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-002731 |
| 2025-11-0408:42 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001104659-25-105962 |
| 2025-11-0408:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-105942 |
| 2025-10-2308:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-101688 |
| 2025-09-2408:39 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-092776 |
| 2025-08-0508:16 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001558370-25-010185 |
| 2025-08-0508:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-010182 |
| 2025-06-1108:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-008525 |
| 2025-06-0508:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-25-008415 |
| 2025-05-1516:30 ET | 8-K | 5.07 Shareholder vote results | 0001558370-25-007894 |
| 2025-05-0608:15 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001558370-25-006394 |
| 2025-05-0608:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-006393 |
| 2025-04-0416:17 ET | DEF 14A | Proxy statementPeriod 2025-05-15 | 0001140361-25-012336 |
| 2025-04-0308:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-004358 |
| 2025-03-2408:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-25-003502 |
| 2025-02-2508:00 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001558370-25-001441 |
| 2025-02-2507:45 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-001439 |
| 2025-01-1308:15 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-000157 |
| 2024-11-0116:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-113484 |
| 2024-10-2908:00 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001558370-24-013803 |
| 2024-10-2907:50 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-013802 |
| 2024-10-0108:45 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-013103 |
| 2024-08-0608:15 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-010960 |
| 2024-08-0608:00 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001558370-24-010956 |
| 2024-07-0116:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-24-009642 |
| 2024-05-2917:01 ET | 8-K | 5.07 Shareholder vote results | 0001558370-24-008734 |
| 2024-05-0308:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001558370-24-006594 |
| 2024-04-3008:00 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001558370-24-006203 |
| 2024-04-3007:45 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-006200 |
| 2024-04-1108:30 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-24-004945 |
| 2024-04-1108:17 ET | DEF 14A | Proxy statementPeriod 2024-05-29 | 0001140361-24-019230 |
| 2024-02-2817:16 ET | 10-K/A | Annual report, amendedPeriod 2023-12-31 | 0001558370-24-002037 |
| 2024-02-2208:00 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001558370-24-001466 |
| 2024-02-2207:45 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-001465 |
| 2024-01-0808:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-000128 |
| 2023-12-0716:06 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001558370-23-019624 |
| 2023-11-0808:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-23-018125 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 16:23 ET. Listed shows no prices and gives no investment advice.